PEEK Interbody Devices Market Size, Share, and Trends 2025 to 2034

The global PEEK interbody devices market size is calculated at USD 2.6 billion in 2025 and is forecasted to reach around USD 5.09 billion by 2034, accelerating at a CAGR of 7.74% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : June 2025
  • Report Code : 6254
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on PEEK Interbody Devices Market 

5.1. COVID-19 Landscape: PEEK Interbody Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global PEEK Interbody Devices Market, By Product Type

8.1. PEEK Interbody Devices Market Revenue and Volume, By Product Type

8.1.1 Posterolateral Fusion Devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Interbody Fusion Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Anterior Lumbar Interbody Fusion Devices (ALIF)

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Extreme Lateral Interbody Fusion Devices (XLIF)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Posterior Lumbar Interbody Fusion Devices (PLIF)

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Transforaminal Lumbar Interbody Fusion Devices (TLIF)

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Other Devices

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global PEEK Interbody Devices Market, By End User

9.1. PEEK Interbody Devices Market Revenue and Volume, By End User

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Ambulatory Surgical Centers (ASCs)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Specialty Clinics

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global PEEK Interbody Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, By Product Type

10.1.2. Market Revenue and Volume Forecast, By End User

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, By Product Type

10.1.3.2. Market Revenue and Volume Forecast, By End User

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, By Product Type

10.1.4.2. Market Revenue and Volume Forecast, By End User

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, By Product Type

10.2.2. Market Revenue and Volume Forecast, By End User

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, By Product Type

10.2.3.2. Market Revenue and Volume Forecast, By End User

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, By Product Type

10.2.4.2. Market Revenue and Volume Forecast, By End User

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, By Product Type

10.2.5.2. Market Revenue and Volume Forecast, By End User

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, By Product Type

10.2.6.2. Market Revenue and Volume Forecast, By End User

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, By Product Type

10.3.2. Market Revenue and Volume Forecast, By End User

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, By Product Type

10.3.3.2. Market Revenue and Volume Forecast, By End User

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, By Product Type

10.3.4.2. Market Revenue and Volume Forecast, By End User

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, By Product Type

10.3.5.2. Market Revenue and Volume Forecast, By End User

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, By Product Type

10.3.6.2. Market Revenue and Volume Forecast, By End User

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, By Product Type

10.4.2. Market Revenue and Volume Forecast, By End User

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, By Product Type

10.4.3.2. Market Revenue and Volume Forecast, By End User

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, By Product Type

10.4.4.2. Market Revenue and Volume Forecast, By End User

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, By Product Type

10.4.5.2. Market Revenue and Volume Forecast, By End User

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, By Product Type

10.4.6.2. Market Revenue and Volume Forecast, By End User

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, By Product Type

10.5.2. Market Revenue and Volume Forecast, By End User

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, By Product Type

10.5.3.2. Market Revenue and Volume Forecast, By End User

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, By Product Type

10.5.4.2. Market Revenue and Volume Forecast, By End User

Chapter 11. Company Profiles

11.1. Medtronic (Ireland)

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Stryker (U.S.)

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. NuVasive, Inc. (U.S.)

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Zimmer Biomet (U.S.)

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Globus Medical (U.S.)

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. DePuy Synthes (U.S.)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Alphatec Spine (U.S.)

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. B. Braun SE (Germany)

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Orthofix Medical Inc. (U.S.)

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. LDR Holding Corporation (U.S.)

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global PEEK interbody devices market is expected to increase from USD 2.41 billion in 2024 to USD 5.09 billion by 2034.

The PEEK interbody devices marketis expected to grow at a compound annual growth rate (CAGR) of around 7.74% from 2025 to 2034.

The major players in the PEEK interbody devices market include Medtronic (Ireland), Stryker (U.S.), NuVasive, Inc. (U.S.), Zimmer Biomet (U.S.) Globus Medical (U.S.), DePuy Synthes (U.S.), Alphatec Spine (U.S.), B. Braun SE (Germany), Orthofix Medical Inc. (U.S.), LDR Holding Corporation (U.S.), SpineArt (Switzerland), Mazor Robotics (Israel), Invibio (UK), Raymedica (U.S.), K2M (U.S.), Finceramica (Italy), Biomet (U.S.), Exactech (U.S.), Japan Medical Materials (Japan), and Curiteva (U.S.).

The driving factors of the PEEK interbody devices market are the growing cases of spinal complications, such as degenerative disc disease, spinal stenosis, and herniated discs, are increasing the need for effective spinal implants, leading to the application of PEEK interbody devices

North America region will lead the global PEEK interbody devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client